tiprankstipranks
Trending News
More News >
Cardiol Therapeutics (TSE:CRDL)
TSX:CRDL
Canadian Market

Cardiol Therapeutics (CRDL) Cash flow

Compare
221 Followers

Cardiol Therapeutics Cash Flow

TSE:CRDL's free cash flow for Q3 2025 was C$-6.93M. For the 2025 fiscal year, TSE:CRDL's free cash flow was decreased by C$-25.08M and operating cash flow was C$-6.93M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
C$ -25.06M-C$ -27.22MC$ -23.55MC$ -9.19M
Investing Cash Flow
C$ -21.29KC$ -64.31KC$ -74.71KC$ -12.92KC$ -40.60K
Financing Cash Flow
C$ 18.84M-C$ -53.93KC$ 93.44MC$ 16.30M
End Cash Position
C$ 30.58MC$ 34.93KC$ 59.47MC$ 83.90MC$ 14.03M
Free Cash Flow
C$ -25.08M-C$ -27.30MC$ -23.56MC$ -9.23M
Currency in CAD

Cardiol Therapeutics Cash Flow